Positive results in Phase 2 trial of treatment of C. difficile-associated diarrhoea
Monday, November 3, 2008 - 11:56
in Health & Medicine
Medarex, Inc. and The Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that a Phase 2 trial of an anti-C. difficile antibody combination treatment in patients with C. difficile Associated Diarrhoea (CDAD) successfully met its primary objective...
Read the whole article on Science Centric
More from Science Centric
Related
- Positive results in Phase 2 trial of treatment of C-difficile-associated diarrheaMon, 3 Nov 2008, 10:50:30 EST
- First human gets new antibody aimed at rabies virusWed, 30 Sep 2009, 14:25:38 EDT
- First human gets new antibody aimed at hepatitis C virusThu, 6 Aug 2009, 11:36:22 EDT
- C. difficile and antibiotics not necessarily linkedTue, 7 Oct 2008, 3:28:46 EDT
- Novel antibody prevents infection by hepatitis C virusTue, 5 May 2009, 14:26:44 EDT